2 August 2016 - Deborah Wilkes
Archived
RB's run of double-digit growth at its Health division has come to an end, after sales of the Scholl/Amopé franchise declined in the second quarter of 2016.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.